Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, et al. N Engl J Med 2024;390:2274-2283.

Read + Share

Amedeo Smart

Independent Medical Education

Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, et al. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. N Engl J Med 2024;390:2274-2283.
PMID: 38767614